Global Peanut Allergy Therapeutics Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Peanut Allergy Therapeutics
- 1.1 Definition of Peanut Allergy Therapeutics
- 1.2 Peanut Allergy Therapeutics Segment by Type
- 1.2.1 Global Peanut Allergy Therapeutics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 ANB-020
- 1.2.3 ANN-004
- 1.2.4 AR-101
- 1.2.5 ASP-0892
- 1.2.6 DBV-712
- 1.2.7 Others
- 1.3 Peanut Allergy Therapeutics Segment by Applications
- 1.3.1 Global Peanut Allergy Therapeutics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Home Care
- 1.4 Global Peanut Allergy Therapeutics Overall Market
- 1.4.1 Global Peanut Allergy Therapeutics Revenue (2014-2025)
- 1.4.2 Global Peanut Allergy Therapeutics Production (2014-2025)
- 1.4.3 North America Peanut Allergy Therapeutics Status and Prospect (2014-2025)
- 1.4.4 Europe Peanut Allergy Therapeutics Status and Prospect (2014-2025)
- 1.4.5 China Peanut Allergy Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Japan Peanut Allergy Therapeutics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Peanut Allergy Therapeutics Status and Prospect (2014-2025)
- 1.4.8 India Peanut Allergy Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Peanut Allergy Therapeutics
- 2.3 Manufacturing Process Analysis of Peanut Allergy Therapeutics
- 2.4 Industry Chain Structure of Peanut Allergy Therapeutics
3 Development and Manufacturing Plants Analysis of Peanut Allergy Therapeutics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Peanut Allergy Therapeutics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Peanut Allergy Therapeutics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Peanut Allergy Therapeutics Production and Capacity Analysis
- 4.2 Peanut Allergy Therapeutics Revenue Analysis
- 4.3 Peanut Allergy Therapeutics Price Analysis
- 4.4 Market Concentration Degree
5 Peanut Allergy Therapeutics Regional Market Analysis
- 5.1 Peanut Allergy Therapeutics Production by Regions
- 5.1.1 Global Peanut Allergy Therapeutics Production by Regions
- 5.1.2 Global Peanut Allergy Therapeutics Revenue by Regions
- 5.2 Peanut Allergy Therapeutics Consumption by Regions
- 5.3 North America Peanut Allergy Therapeutics Market Analysis
- 5.3.1 North America Peanut Allergy Therapeutics Production
- 5.3.2 North America Peanut Allergy Therapeutics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Peanut Allergy Therapeutics Import and Export
- 5.4 Europe Peanut Allergy Therapeutics Market Analysis
- 5.4.1 Europe Peanut Allergy Therapeutics Production
- 5.4.2 Europe Peanut Allergy Therapeutics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Peanut Allergy Therapeutics Import and Export
- 5.5 China Peanut Allergy Therapeutics Market Analysis
- 5.5.1 China Peanut Allergy Therapeutics Production
- 5.5.2 China Peanut Allergy Therapeutics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Peanut Allergy Therapeutics Import and Export
- 5.6 Japan Peanut Allergy Therapeutics Market Analysis
- 5.6.1 Japan Peanut Allergy Therapeutics Production
- 5.6.2 Japan Peanut Allergy Therapeutics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Peanut Allergy Therapeutics Import and Export
- 5.7 Southeast Asia Peanut Allergy Therapeutics Market Analysis
- 5.7.1 Southeast Asia Peanut Allergy Therapeutics Production
- 5.7.2 Southeast Asia Peanut Allergy Therapeutics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Peanut Allergy Therapeutics Import and Export
- 5.8 India Peanut Allergy Therapeutics Market Analysis
- 5.8.1 India Peanut Allergy Therapeutics Production
- 5.8.2 India Peanut Allergy Therapeutics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Peanut Allergy Therapeutics Import and Export
6 Peanut Allergy Therapeutics Segment Market Analysis (by Type)
- 6.1 Global Peanut Allergy Therapeutics Production by Type
- 6.2 Global Peanut Allergy Therapeutics Revenue by Type
- 6.3 Peanut Allergy Therapeutics Price by Type
7 Peanut Allergy Therapeutics Segment Market Analysis (by Application)
- 7.1 Global Peanut Allergy Therapeutics Consumption by Application
- 7.2 Global Peanut Allergy Therapeutics Consumption Market Share by Application (2014-2019)
8 Peanut Allergy Therapeutics Major Manufacturers Analysis
- 8.1 Adverum Biotechnologies Inc
- 8.1.1 Adverum Biotechnologies Inc Peanut Allergy Therapeutics Production Sites and Area Served
- 8.1.2 Adverum Biotechnologies Inc Product Introduction, Application and Specification
- 8.1.3 Adverum Biotechnologies Inc Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Aimmune Therapeutics Inc
- 8.2.1 Aimmune Therapeutics Inc Peanut Allergy Therapeutics Production Sites and Area Served
- 8.2.2 Aimmune Therapeutics Inc Product Introduction, Application and Specification
- 8.2.3 Aimmune Therapeutics Inc Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Alfacyte Ltd
- 8.3.1 Alfacyte Ltd Peanut Allergy Therapeutics Production Sites and Area Served
- 8.3.2 Alfacyte Ltd Product Introduction, Application and Specification
- 8.3.3 Alfacyte Ltd Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Allergy Therapeutics Plc
- 8.4.1 Allergy Therapeutics Plc Peanut Allergy Therapeutics Production Sites and Area Served
- 8.4.2 Allergy Therapeutics Plc Product Introduction, Application and Specification
- 8.4.3 Allergy Therapeutics Plc Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 AnaptysBio Inc
- 8.5.1 AnaptysBio Inc Peanut Allergy Therapeutics Production Sites and Area Served
- 8.5.2 AnaptysBio Inc Product Introduction, Application and Specification
- 8.5.3 AnaptysBio Inc Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 ASIT Biotech SA
- 8.6.1 ASIT Biotech SA Peanut Allergy Therapeutics Production Sites and Area Served
- 8.6.2 ASIT Biotech SA Product Introduction, Application and Specification
- 8.6.3 ASIT Biotech SA Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Astellas Pharma Inc
- 8.7.1 Astellas Pharma Inc Peanut Allergy Therapeutics Production Sites and Area Served
- 8.7.2 Astellas Pharma Inc Product Introduction, Application and Specification
- 8.7.3 Astellas Pharma Inc Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 BioLingus AG
- 8.8.1 BioLingus AG Peanut Allergy Therapeutics Production Sites and Area Served
- 8.8.2 BioLingus AG Product Introduction, Application and Specification
- 8.8.3 BioLingus AG Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 DBV Technologies SA
- 8.9.1 DBV Technologies SA Peanut Allergy Therapeutics Production Sites and Area Served
- 8.9.2 DBV Technologies SA Product Introduction, Application and Specification
- 8.9.3 DBV Technologies SA Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 HAL Allergy BV
- 8.10.1 HAL Allergy BV Peanut Allergy Therapeutics Production Sites and Area Served
- 8.10.2 HAL Allergy BV Product Introduction, Application and Specification
- 8.10.3 HAL Allergy BV Peanut Allergy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Intrommune Therapeutics
- 8.12 Sanofi
- 8.13 Selecta Biosciences Inc
9 Development Trend of Analysis of Peanut Allergy Therapeutics Market
- 9.1 Global Peanut Allergy Therapeutics Market Trend Analysis
- 9.1.1 Global Peanut Allergy Therapeutics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Peanut Allergy Therapeutics Regional Market Trend
- 9.2.1 North America Peanut Allergy Therapeutics Forecast 2019-2025
- 9.2.2 Europe Peanut Allergy Therapeutics Forecast 2019-2025
- 9.2.3 China Peanut Allergy Therapeutics Forecast 2019-2025
- 9.2.4 Japan Peanut Allergy Therapeutics Forecast 2019-2025
- 9.2.5 Southeast Asia Peanut Allergy Therapeutics Forecast 2019-2025
- 9.2.6 India Peanut Allergy Therapeutics Forecast 2019-2025
- 9.3 Peanut Allergy Therapeutics Market Trend (Product Type)
- 9.4 Peanut Allergy Therapeutics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Peanut Allergy Therapeutics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Peanut Allergy Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Peanut Allergy Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peanut Allergy Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Peanut Allergy Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Peanut Allergy Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Adverum Biotechnologies Inc
Aimmune Therapeutics Inc
Alfacyte Ltd
Allergy Therapeutics Plc
AnaptysBio Inc
ASIT Biotech SA
Astellas Pharma Inc
BioLingus AG
DBV Technologies SA
HAL Allergy BV
Intrommune Therapeutics
Sanofi
Selecta Biosciences Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
ANB-020
ANN-004
AR-101
ASP-0892
DBV-712
Others
Segment by Application
Clinic
Hospital
Home Care